- Summits
- Sponsorship
- Media Opportunities
- News
- About
On the first day of the conference of MedTech World Middle East, a panel titled “The GCC MedTech Boom Today: State of the Market, Funding and Scaling Healthcare Innovation” explored how healthcare innovation is growing quickly in the region. Speakers discussed the move toward digital health, new funding opportunities, and ways to expand MedTech solutions across the GCC.
The panel included Dr Khalid Kheder, Advisor to H.E. Vice Minister for Planning and Development, Ministry of Health Saudi Arabia and the Board Chairman of the Quality in Health Care Association; Dr. Alireza Daneshvar, Founder & CEO of Pioneera Biosciences; Dr. Yazeed Alsufyani, CEO & General Partner of IB Ventures; Dr. Ruchi Dana, Partner at MFV Partners; and Dr. Dimah AlSaqabi, Healthcare Consultant at Welcome Health Ventures. Matt Foran, Healthcare Principal at LEAD VC, moderated the discussion, which focused on the GCC’s growing role as a MedTech investment hub and how government initiatives are supporting innovation.
The GCC healthcare market is changing quickly, thanks to major public investment and government reforms. Dr. Khalid Kheder highlighted the region’s potential, saying, “The GCC is no longer just a consumer of healthcare; it is becoming an attractive hub for innovation and investment.” Ambitious national goals and fast digital adoption are helping the region become a key player in global healthcare.
As the GCC adopts digital health solutions, partnerships are key to growing new healthcare technologies. Dr. Dimah AlSaqabi explained that Welcome Health Ventures helps international startups enter the market, saying, “We help companies understand local healthcare needs and connect them with the right stakeholders to ensure their solutions fit the GCC market.” This shows how important local partnerships are for handling market entry, reimbursement, and regulations.
Dr. Yazeed Alsufyani talked about the need for smart funding to help biotech and MedTech companies grow. He said, “We focus on early-stage biotech companies and aim to bridge global innovations with Saudi Arabia’s Vision 2030 goals to foster local entrepreneurship.” With IB Ventures, the first biotech investment fund in Saudi Arabia, the region is drawing more international attention.
Dr. Ruchi Dana, Partner at MFV Partners, spoke about the potential for robotics and AI in MedTech. She said that working together across public and private sectors is essential for lasting growth. She added, “It’s not just about building technology; it’s about building trust and relationships with the community and the healthcare professionals who will use it.” Her focus on the human side of healthcare innovation matched the conference’s main message: technology should always put patient outcomes first.
As the region continues to invest in healthcare infrastructure and digital health solutions, it is clear that the GCC is poised to become a global leader in MedTech innovation. The panellists agreed that government commitment, regulatory support, and an expanding investment ecosystem will accelerate the region’s MedTech growth. Dr. Alireza Daneshvar, CEO of Pioneera Biosciences, captured the essence of the region’s future potential, stating, “The golden era for MedTech in the GCC is now, with regulatory frameworks evolving and public policy supporting biotech breakthroughs.”
At the end of the session, moderator Matt Foran encouraged everyone to get involved in the fast-growing MedTech scene in the region. “Whether you’re a startup or an investor, the GCC offers unparalleled opportunities to scale and innovate. It’s a market that is ripe for transformation and collaboration.”
With the success of this panel, MedTech World Middle East continues to set the stage for deeper engagement and exploration of healthcare innovation across the region. The next MedTech World event, MedTech World North America, will take place in Florida, USA, from 11–13 May 2026. To participate, reserve your slot now.
